{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:52:07Z","timestamp":1790790727776,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s13730-020-00475-9","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:02:22Z","timestamp":1587168142000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient"],"prefix":"10.1007","volume":"9","author":[{"given":"Tomoya","family":"Kaneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Akutsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,18]]},"reference":[{"issue":"8","key":"475_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347(8):589\u2013600.","journal-title":"N Engl J Med"},{"issue":"7","key":"475_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654\u201366.","journal-title":"N Engl J Med"},{"issue":"2","key":"475_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2215\/CJN.00620117","volume":"13","author":"V Brocklebank","year":"2018","unstructured":"Brocklebank V, Wood KM, Kavanagh D. Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol. 2018;13(2):300\u201317.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"12","key":"475_CR4","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s10067-017-3823-2","volume":"36","author":"M de Holanda","year":"2017","unstructured":"de Holanda M, P\u00f4rto L, Wagner T, Christiani L, Palma L. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1\u2013CFHR3. A case report and systematic review. Clin Rheumatol. 2017;36(12):2859\u201367.","journal-title":"Clin Rheumatol."},{"issue":"1","key":"475_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10067-017-3793-4","volume":"37","author":"F Sun","year":"2018","unstructured":"Sun F, Wang X, Wu W, et al. TMA secondary to SLE: rituximab improves overall but not renal survival. Clin Rheumatol. 2018;37(1):213\u20138.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"475_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0049-0172(94)90072-8","volume":"24","author":"G Nesher","year":"1994","unstructured":"Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum. 1994;24(3):165\u201372.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"475_CR7","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1503\/cmaj.160142","volume":"189","author":"DM Arnold","year":"2017","unstructured":"Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ. 2017;189(4):E153\u2013E159159.","journal-title":"CMAJ"},{"issue":"4","key":"475_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/rheumatology\/ken510","volume":"48","author":"P Letchumanan","year":"2009","unstructured":"Letchumanan P, Ng HJ, Lee LH, Thumboo J. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus. Rheumatology. 2009;48(4):399\u2013403.","journal-title":"Rheumatology"},{"issue":"1","key":"475_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13052-019-0641-y","volume":"45","author":"J Li","year":"2019","unstructured":"Li J, Jiang JJ, Wang CY, Jian S, Zhou Y, Ma MS, et al. Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases. Ital J Pediatr. 2019;45(1):55.","journal-title":"Ital J Pediatr"},{"issue":"18","key":"475_CR10","doi-asserted-by":"publisher","first-page":"e3595","DOI":"10.1097\/MD.0000000000003595","volume":"95","author":"QY Li","year":"2016","unstructured":"Li QY, Yu F, Zhou FD, Zhao MH. Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy: a case series study. Medicine (Baltimore). 2016;95(18):e3595.","journal-title":"Medicine (Baltimore)"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00296-017-3686-5","volume":"37","author":"S Sciascia","year":"2017","unstructured":"Sciascia S, Radin M, Yazdany J, et al. Expanding the therapeutic options for renal involvement in lupus: Eculizumab, available evidence. Rheumatol Int. 2017;37:1249\u201355.","journal-title":"Rheumatol Int"},{"issue":"4","key":"475_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.rdc.2018.06.010","volume":"44","author":"F Babar","year":"2018","unstructured":"Babar F, Cohen SD. Thrombotic microangiopathies with rheumatologic involvement. Rheum Dis Clin N Am. 2018;44(4):635\u201349.","journal-title":"Rheum Dis Clin N Am"},{"key":"475_CR13","unstructured":"Takei S. Study on refractory pathology and treatment of childhood systemic lupus erythematosus (SLE): research on diagnosis and treatment of refractory pathology of rheumatic and collagen disease in childhood. 2010 Summary Research Report, pp\u00a074\u201378. 2011. (article in Japanese)"},{"issue":"10","key":"475_CR14","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.autrev.2019.102361","volume":"18","author":"O Omarjee","year":"2019","unstructured":"Omarjee O, Picard C, Frachette C, Moreews M, Rieux-Laucat F, Soulas-Sprauel P, et al. Monogenic lupus: dissecting heterogeneity. Autoimmun Rev. 2019;18(10):102361.","journal-title":"Autoimmun Rev"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00475-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T23:08:23Z","timestamp":1618700903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00475-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,18]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00475-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,18]]},"assertion":[{"value":"5 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Research funding: Masaaki Mori, Nippon Kayaku Co., Ltd., Asahi Kasei Pharma Co., AbbVie GK, Mitsubishi Tanabe Pharma Co. Donations: Tomohiro Morio, Astellas Pharma Inc.. Endowed departments by commercial entities: Mariko Mouri, and Masaaki Mori, Chugai Pharmaceutical Co., Ltd., UCB Japan Co. Ltd., CSL Behring K.K., Japan Blood Products Organization, and AYUMI Pharmaceutical Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent for publication of this article was obtained from the patient and her parents verbally and by a written document.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}